http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016066687-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aff7364e15f7656fe18847ce1648808
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
filingDate 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d2ef2311064180d1474d55e8bf87845
publicationDate 2016-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016066687-A1
titleOfInvention Losmapimod for treating copd
abstract The use of p38 kinase inhibitors in the treatment of sub-populations of COPD patients.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10342786-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11479770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291659-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10537560-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4159212-A1
priorityDate 2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11151296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228171297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227317473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11552706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229133513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22049997

Total number of triples: 28.